Personal tools

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit

Updates regarding government operating status and resumption of normal operations can be found at

You are here: Home / Biomarkers / TNFSF10



This biomarker is also known as:
  • APO2L,
  • tumor necrosis factor (ligand) superfamily, member 10,
  • tumor necrosis factor (ligand) family, member 10,
  • tumor necrosis factor ligand superfamily member 10,
  • CD253,
  • TL2,
  • Apo-2L,
  • tumor necrosis factor apoptosis-inducing ligand splice variant delta,
  • chemokine tumor necrosis factor ligand superfamily member 10,
  • TNF-related apoptosis inducing ligand TRAIL,
  • TRAIL,
  • CD253 antigen,
  • TNF-related apoptosis-inducing ligand,
  • Protein TRAIL,
  • Apo-2 ligand,


tumor necrosis factor (ligand) superfamily, member 10


QA State: Curated
Type: Gene
Short Name:


There are no datasets associated with this biomarker.


The following organs have data associated with this biomarker…



Phase: One
QA State: Under Review


No additional prostate data available.

Performance Comment

19 common probe sets (15 unique genes) were used to develop a PAM-based classifier, which had an average accuracy of 87% when it was tested on 47 independent tumor-adjacent stroma samples. The 15 genes represented in the classifier are: GADD45B, CDKN1A, NLRP1, ERBB3, FMO5, KIAA0746///SERINC2, AMFR, DPP4, PGC, YWHAE, EHF, TF, TNFSF10, EIF5A, TGM4. This is the first general tumor microenvironment-based prognostic classifier. Tumor-adjacent prostate cancer stroma contains numerous changes in gene expression at the time of diagnosis that correlate with the chance of relapse following prostatectomy. These results indicate that the prostate cancer microenvironment exhibits reproducible changes useful for predicting outcomes for patients.


This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at if you should have access to this biomarker.


Mutation Statistics

Gene Name: TNFSF10
UniProt Accession #: P50591
Mutated Sites Count: 39
Associated Pubmed ID Count 8
CancerDO Count 18
Affected Protein Function Sites Count: 3

View in BioMuta